Motley FoolIs Pfizergan Really That Unpalatable?Motley FoolJudging by the market's initial reaction, investors would appear to think that the megamerger between pharma giants Allergan (NYSE:AGN) and Pfizer (NYSE:PFE) is simply a bad idea. Perhaps most telling, Allergan finished the day down 3.4% and Pfizer's ...Ireland, the tax haven of choice for PfizerLos Angeles TimesNeed inversion conversionChampaign/Urbana News-GazettePfizer to buy Allergan in world's largest ever health care dealJewocity.com (press release) (blog)Dubuque Telegraph Herald -NYSE Post -Defiance Crescent News (subscription) -Xinhuanet Searchall 102 news articles »